Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

Topp MS, Shah BD, Jabbour E, Park JH, Shaughnessy P, Logan AC, Sandhu KS, Abedi M, Bishop MR, DeAngelo DJ, Yin X, Davi R, Hodby K, Malladi R, Brugger W, Shang J, Roddie C, Kantarjian HM

Open source

DOI
10.1038/s41375-026-03045-7
Published
2026 Oct
Container
Leukemia
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41375-026-03045-7,
  title = {Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.},
  author = {Topp MS and Shah BD and Jabbour E and Park JH and Shaughnessy P and Logan AC and Sandhu KS and Abedi M and Bishop MR and DeAngelo DJ and Yin X and Davi R and Hodby K and Malladi R and Brugger W and Shang J and Roddie C and Kantarjian HM},
  year = {2026},
  journal = {Leukemia},
  doi = {10.1038/s41375-026-03045-7},
  url = {https://doi.org/10.1038/s41375-026-03045-7}
}

RIS

TY  - JOUR
TI  - Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
AU  - Topp MS
AU  - Shah BD
AU  - Jabbour E
AU  - Park JH
AU  - Shaughnessy P
AU  - Logan AC
AU  - Sandhu KS
AU  - Abedi M
AU  - Bishop MR
AU  - DeAngelo DJ
AU  - Yin X
AU  - Davi R
AU  - Hodby K
AU  - Malladi R
AU  - Brugger W
AU  - Shang J
AU  - Roddie C
AU  - Kantarjian HM
PY  - 2026
JO  - Leukemia
DO  - 10.1038/s41375-026-03045-7
UR  - https://doi.org/10.1038/s41375-026-03045-7
ER  - 

APA

MS, T., BD, S., E, J., JH, P., P, S., AC, L., KS, S., M, A., MR, B., DJ, D., X, Y., R, D., K, H., R, M., W, B., J, S., C, R., & HM, K. (2026). Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.. Leukemia. https://doi.org/10.1038/s41375-026-03045-7

Source records